Skip to Content
No Fees Unless We Win 855-948-5098
Top
Page Two Client Focused. Trial Ready. Billions Won.

Monsanto Papers | Secret Documents | Page Two

Issue: Ghostwriting, Peer-Review & Retraction…continued

6. Email Confirming Monsanto’s Intention to Pay Wallace Hayes (Editor of Food and Chemical Toxicology) as Consultant
No: MONGLY00971543
Date: 8/12/2012 – 8/13/2012
Documents Released: 8/1/2017

Description
This document is an email from Dr. David Saltmiras to Dr. Heydens wherein Dr. Saltmiras “Contact Wallace Hayes to determine his availability and fees for attending the meeting.”

Relevance
The document does not contain trade secrets, sensitive commercial information or privileged material. This document is relevant and reasonably likely to be used in this litigation for the same reasons as the above (MONGLY02185742) document. Mr. Hayes’ paid consultancy for Monsanto constitutes a conflict of interest with his role as editor of a journal publishing research on glyphosate- especially given his involvement in retracting a study pertaining to the biological plausibility of glyphosate as a human carcinogen. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

7. Monsanto Consulting Agreement with Food and Chemical Toxicology Editor Preceding Journal’s Retraction of Seralini Study
No: MONGLY02185742
Date: 8/21/2012
Documents Released: 8/1/2017

Description
This document is a 2012 consulting agreement between Monsanto and editor of Food and Chemical Toxicology, Wallace Hayes for the period immediately preceding Mr. Hayes’s involvement in the retraction of the Seralini paper from Food and Chemical Toxicology.

Relevance
This document is relevant and reasonably likely to be used in this litigation as it demonstrates the conflict of interest between Mr. Hayes’ role as a consultant for Monsanto and his vocation as editor for a research journal which retracted a study determining that glyphosate is capable of being a carcinogen. The document is further indication of Monsanto’s pervasive influence within the scientific community which is related to the availability and quality of data on glyphosate used by researchers and regulators to assess the scientific literature in determining the potential carcinogenicity of glyphosate. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

8. Monsanto Email Confirming Company’s Intimate Relationship with Wallace Hayes, Editor of Food and Chemical Toxicology Journal
No: MONGLY01096619
Date: 9/19/2012 – 9/20/2012
Documents Released: 8/1/2017

Description
This document contains an email correspondence between various Monsanto personnel wherein Dr. Saltmiras expresses the following with respect to the recently published study in Food and Chemical Toxicology by Seralini: “Wally Hayes, now FCT Editor in Chief for Vision and Strategy, sent me a courtesy email early this morning. Hopefully the two of us will have a follow up discussion soon to touch on whether I C’I’ Vision and Strategy were front and center for this one passing through the peer review process…. and what is that, Vision and Strategy? I also suspect this paper may be in our own best interests – the last rites for Seralini’s few remaining shreds of scientific credibility.” at *2.

Relevance
This document is relevant and reasonably likely to be used in this litigation as it confirms Monsanto’s intimate relationship with Wallace Hayes who was subsequently involved in retracting professor Seralini’s study pertaining to the biological plausibility of glyphosate as a human carcinogen, a conclusion that was adverse to Monsanto’s commercial agenda. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

9. Email from Monsanto Collaborator Bruce Chassy to Editor of Food and Chemical Toxicology Journal Urging Seralini Study Retraction
No: MONGLY00900629
Date: 9/26/2012
Documents Released: 8/1/2017

Description

This document contains email correspondence between Bruce Chassy and the Editor of Food and Chemical Toxicology, Wallace Hayes, wherein Dr. Chassy urges Mr. Hayes to retract the Seralini paper at Monsanto’s request (discussed above): “My intent was to urge you to roll back the clock, retract the paper, and restart the review process.” at *2.

Relevance
This document is relevant and reasonably likely to be used in this litigation as it confirms Monsanto’s campaign to eliminate a study which observed the adverse effects of glyphosate. It is relevant for the same reasons as documents MONGLY02063095 and MONGLY01045298. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

10. Monsanto Email Chain: Personnel Discusses Plan Seeking Retraction of Seralini Glyphosate Study
No: MONGLY02063095
Date: 9/26/2012
Documents Released: 8/1/2017

Description
This document contains a series of email exchanges between various Monsanto personnel regarding letters to the editor of Food and Chemical Toxicology seeking retraction of a study by Professor G.E. Seralini. Mr. Eric Sachs writes about his efforts to galvanize scientists in a letter-writing campaign in order to retract the article: “I talked to Bruce Chassy and he will send his letter to Wally Hayes directly and notify other scientists that have sent letters to do the same. He understands the urgency…I remain adamant that Monsanto must: not be put: in the position of providing the critical analysis that leads the editors to retract the paper.” at *3, 2; see also MONGLY01045298 (below).

Relevance
This document is relevant and reasonably likely to be used in this litigation as it demonstrates the significant role played by Monsanto in achieving the successful retraction of a scientific study without appearing to be directly involved in such efforts. Monsanto’s influence on the quality and quantity of scientific data on glyphosate is related to the conclusions that regulators and researchers are able to reach with respect to whether carcinogenicity is a biologically plausible feature of glyphosate. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

11. Monsanto Email Chain Confirming Undisclosed Involvement in Successful Retraction of Seralini Study
No: MONGLY00936725
Date: 9/28/2012
Documents Released: 8/1/2017

Description

This document contains email correspondence between Dr. Goldstein and Eric Sachs regarding the Monsanto campaign to retract professor Seralini’s paper. Dr. Goldstein states: “I was uncomfortable even letting shareholders know we are aware of this LTE…. It implies we had something to do with it- otherwise how do we have knowledge of it? I could add ‘Aware of multiple letters to editor including one signed by 25 scientists from 14 countries’ if you both think this is OK.” at *1. Mr. Sachs responds: “We are ‘connected’ but did not write the letter or encourage anyone to sign it.” Id.

Relevance
This document is relevant and reasonably likely to be used in this litigation as confirms Monsanto’s undisclosed involvement in the successful retraction of a paper pertaining to the biological plausibility of glyphosate as a human carcinogen; a conclusion adverse to Monsanto’s commercial agenda. Moreover, the document demonstrates that Monsanto personnel were aware of the imperative need to covertly instigate the retraction campaign and the inappropriateness of such action. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

12. Monsanto Email Confirming Attempt to Seek Retraction of Seralini Study
No: MONGLY00978886
Date: 10/9/2012 – 10/10/2012
Documents Released: 8/1/2017

Description
This document contains email correspondence between various Monsanto personnel wherein Daniel Goldstein writes the following with respect to professor Seralini’s study: “Retraction- Both Dan Jenkins (US Government affairs) and Harvey Glick made a strong case for withdrawal of the paper if at all possible, both on the same basis- that publication will elevate the status of the paper, bring other papers in the journal into question, and allow Seralini much more freedom to operate. All of us are aware that the ultimate decision is up to the editor and the journal management, and that we may not have an opportunity for withdrawal in any event, but I felt it was worth reinforcing this request.” at *3.

Relevance
The document does not contain trade secrets, sensitive commercial information or privileged material. This document is relevant and reasonably likely to be used in this litigation as it confirms Monsanto’s attempt to seek retraction of a study pertaining to the biological plausibility of glyphosate as a human carcinogen; a conclusion adverse to Monsanto’s commercial agenda. Mr. Goldstein makes it clear that a retraction would curtail professor Seralini’s “freedom to operate.” Id. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility

13. Monsanto Scientist David Saltmiras Admits to Leveraging Relationship with Editor of Food and Chemical Toxicology Journal in Effort to Retract Seralini Study
No: MONGLY01045298
Date: 8/20/2013
Documents Released: 8/1/2017

Description
This document identifies the “Business Goals” of Monsanto employee David Saltmiras for the fiscal year 2013. Dr. Saltmiras explicitly states under the “Employee Comments” section: “Throughout the late 2012 Seralini rat cancer publication and media campaign, I leveraged my relationship the Editor of Chief of the publishing journal, Food and Chemical Toxicology and was the single point of contact between Monsanto and the Journal.” at 6. Moreover, Dr. Saltmiras acknowledges that he “[s]uccessfully facilitated numerous third party expert letters to the editor which were subsequently published, reflecting the numerous significant deficiencies, poor study design, biased reporting and selective statistics employed by Seralini.” at 3.

Relevance
This document is relevant and reasonably likely to be used in this litigation for similar reasons as the previous (MONGLY02063095) document. Dr. Saltmiras acknowledges Monsanto’s intimate contact with the editor of FCT which, per document MONGLY02063095, led to the retraction of professor Seralini’s study from Food and Chemical Toxicology. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

14. Email Correspondence Wherein William Heydens Suggests Experts Could ‘Edit & Sign Their Names’ to Scientific Paper
No: MONGLY00977264 – MONGLY00977270
Date: 2/2015
Documents Released: 3/14/2017

Description
These documents contain email correspondences between William Heydens and other Monsanto personnel. In one exchange, Heydens suggests adding the names of experts to scientific papers to cut down on costs (a practice used by Monsanto in the past): “An option would be to add Greim and Kier or Kirkland to have their names on the publication, but we would be keeping the cost down by us doing the writing and they would just edit & sign their names so to speak. Recall that is how we handled Williams Kroes & Munro, 2000.

15. Internal Monsanto Email Detailing Company Effort to Preemptively Criticize IARC in the Press Ahead of Glyphosate Report
No: MONGLY01005425
Date: 2/23/2015 – 2/24/2015
Documents Released: 8/1/2017

Description
This document contains email correspondence between Eric Sachs (Monsanto) and Henry Miller, a Forbes contributor and fellow of the Stanford Hoover institute. Mr. Sachs asks Mr. Miller: “Are you interested in writing a column on this topic? Ideally, your article would precede the IARC decision. Why not set the table with the weight of scientific evidence before IARC convenes? Then, regardless of what they do, your article will set the stage for a science-based response.” at *2. Moreover, Mr. Sachs informs his Monsanto colleagues: “Henry agreed to author an article on Forbes.com. John will work with a team internally to provide a draft and Henry will edit/add to make it his own.” at *1.

Relevance
This document is relevant and reasonably likely to be used in this litigation as it demonstrates Monsanto’s effort to criticize IARC in anticipation of a general causation classification. Monsanto is a significant contributor to the article without disclosing its interest and involvement. The reliability and consensus of scientific literature is directly relevant to general causation. This document also goes to witness credibility.

Wisner Baum's Case Results

  • $10 Million Settlement A Major Foreign Plane Crash

    Wisner Baum obtained a $10 million settlement for the death of a passenger in a major foreign plane crash.

  • $14 Million Settlement A Major US Plane Crash

    Wisner Baum obtained a $14 million settlement for the death of a passenger in a major US plane crash.

  • $17.5 Million Settlement A Major US Plane Crash

    Wisner Baum obtained a $17.5 million settlement on behalf of a client who was killed in a major U.S. plane crash.

  • $10 Million Settlement Celexa-Lexapro Pediatric Class Action

    $10 million pediatric class action re false promotion of Celexa and Lexapro. Babies born to women who have used Lexapro and other similar medications such as Zoloft, Celexa, Prozac, Paxil, and Symbyax are at an increased risk for birth defects.

  • $8.5 Million Verdict Commercial Truck Accident

    Wisner Baum secured a $8.5 million wrongful death verdict against the food industry company, Tyson Foods, for the wrongful death of a young man.

  • $28 Million Settlement Defective Drug Class Action

    $28 million Paxil defective drug class action. A class action has been brought in the US territory of Puerto Rico against UK-based drug major GlaxoSmithKline.

Client-Focused Representation

REVIEWS & TESTIMONIALS

We believe our track record speaks for itself. But you don’t have to take our word for it. See what our clients have to say about working with us.

    "I Can’t Imagine a Better Law Firm"

    Multiple lawyers recommended Wisner Baum to me and I have been consistently impressed with the quality of their work.

    - Best Law Firms Survey
    "They Are About Changing the Systems..."

    Wisner Baum are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.

    - Kim Witczak
    "Top Legal Minds in the Country"

    The Wisner Baum firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.

    - From Best Lawyers® Best Law Firms
Nationwide Legal Advocacy Call (855) 948-5098 to Learn About Your Legal Options Free & Confidential Consultation